Skip to content
10-K/A

Annual Report

Immunoclin Corp

0001517126-14-000201

← back to feed
Filed
Jul 7, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Jun 30, 2014 26.47M sh
Capex FY 2014 · Jan 31, 2014 $6.59K
Operating Cash Flow FY 2014 · Jan 31, 2014 −$110.63K
Operating Cash Flow FY 2014 · Jan 31, 2013 $156K
Stockholders Equity FY 2014 · Jan 31, 2014 $20.31M
Stockholders Equity FY 2014 · Jan 31, 2013 −$310.39K
Stockholders Equity FY 2014 · Jan 31, 2012 −$280.84K
Current Liabilities FY 2014 · Jan 31, 2014 $725.47K
Current Liabilities FY 2014 · Jan 31, 2013 $513.2K
Current Assets FY 2014 · Jan 31, 2014 $584.34K
Current Assets FY 2014 · Jan 31, 2013 $201.55K
Total Assets FY 2014 · Jan 31, 2014 $21.04M
Total Assets FY 2014 · Jan 31, 2013 $202.81K
Sga Expense FY 2014 · Jan 31, 2014 $167.46K
Sga Expense FY 2014 · Jan 31, 2013 $143.42K
Rd Expense FY 2014 · Jan 31, 2014 $98.28K
Rd Expense FY 2014 · Jan 31, 2013 $93.12K
Net Income FY 2014 · Jan 31, 2014 −$12.98M
Net Income FY 2014 · Jan 31, 2013 −$68.44K
Operating Income FY 2014 · Jan 31, 2014 −$12.98M
Operating Income FY 2014 · Jan 31, 2013 −$144.19K
Revenue FY 2014 · Jan 31, 2013 $182.62K